Bills · 2021-2022 Regular Session
Relating to: prescription drug purchasing entity study.
Drugs Insurance — Commissioner office of
- Introduced, stopped here
- Passes Assembly, not reached
- Passes Senate, not reached
- Governor signs, not reached
- Law, not reached
Unfamiliar terms? Glossary
What this bill does
Plain-language analysis by the nonpartisan Legislative Reference Bureau
This bill requires the Office of the Commissioner of Insurance to conduct a
study on the viability of creating or implementing a state prescription drug
purchasing entity.
Sponsors
Introduced by: Anderson (D) , B. Meyers (D) , Cabrera (D) , Conley (D) , Considine (D) , Emerson (D) , Hebl (D) , Hesselbein (D) , Hong (D) , L. Myers (D) , Milroy (D) , Neubauer (D) , Pope (D) , S. Rodriguez (D) , Shankland (D) , Shelton (D) , Sinicki (D) , Snodgrass (D) , Spreitzer (D) , Stubbs (D) , Subeck (D) , Vruwink (D)
Full history
- Sep 10, 2021 · Assembly
Introduced by Representatives Subeck, Anderson, Cabrera, Conley, Considine, Emerson, Hebl, Hesselbein, Hong, B. Meyers, Milroy, L. Myers, Neubauer, Pope, S. Rodriguez, Shankland, Shelton, Sinicki, Snodgrass, Spreitzer, Stubbs and Vruwink; cosponsored by Senators Erpenbach, Johnson, Agard, Bewley, Carpenter, Larson, Pfaff, Ringhand, Roys and Wirch
- Sep 10, 2021 · Assembly
Read first time and referred to Committee on Insurance
- Mar 15, 2022 · Assembly
Failed to pass pursuant to Senate Joint Resolution 1